Home › NDC Lookup › RxCUI directory › RxCUI 309329

Clindamycin 75 MG Oral Capsule — RxCUI 309329

RxNorm drug concept · Semantic clinical drug
RxCUI 309329 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 41 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309329
Official nameClindamycin 75 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclindamycin (as clindamycin hydrochloride) 75 MG Oral Capsule; clindamycin HCl 75 MG Oral Capsule
FDA products mapped15
Package NDCs mapped41
Reported Medicaid activity (SDUD)395,217 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clindamycin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats bacterial vaginosis, a vaginal infection caused by an imbalance of bacteria. It can be used in non-pregnant women and in pregnant women in the second and third trimester....
  • It's best not to. The cream contains mineral oil that can weaken latex condoms and diaphragms. Avoid them during treatment and for 5 days afterward, because they may not prevent pr...
  • Some women get a vaginal yeast infection or vaginal irritation. These were the most common in trials. Let your prescriber know if symptoms bother you.
  • Call if you get diarrhea, especially if it is bloody or doesn't go away. Antibiotics can allow a harmful bowel germ to overgrow, and this can happen even weeks after treatment. Als...
📖 Read our full Clindamycin Topical guide →

🕸️ Concept Web — How Clindamycin 75 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clindamycin 75 MG Oral Capsule RxCUI 309329

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clindamycin 2582
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • ANTIROBE 94794
    • Cleocin 202862
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clindamycin Oral Capsule 371555
    • Clindamycin Oral Product 1152785
    • Clindamycin Pill 1152786
    • Clindamycin Oral Capsule [ANTIROBE] 629318
    • Clindamycin Oral Capsule [Cleocin] 748745
    • ANTIROBE Oral Product 1165931
    • ANTIROBE Pill 1165932
    • Cleocin Oral Product 1172331
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Clindamycin 75 MG 330450
    • Clindamycin 75 MG Oral Capsule [ANTIROBE] 629324
    • Clindamycin 75 MG Oral Capsule [Cleocin] 748750
    • Clindamycin 75 MG [ANTIROBE] 629323
    • Clindamycin 75 MG [Cleocin] 748749

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clindamycin 75 MG SCDC · 330450
  • Clindamycin Oral Capsule SCDF · 371555
  • Clindamycin Oral Product SCDG · 1152785
  • Clindamycin Pill SCDG · 1152786

Brand-Name Concepts

  • Clindamycin 75 MG Oral Capsule [Cleocin] SBD · 748750
  • Clindamycin 75 MG Oral Capsule [ANTIROBE] SBD · 629324
  • Clindamycin 75 MG [ANTIROBE] SBDC · 629323
  • Clindamycin 75 MG [Cleocin] SBDC · 748749
  • Clindamycin Oral Capsule [ANTIROBE] SBDF · 629318
  • Clindamycin Oral Capsule [Cleocin] SBDF · 748745
  • ANTIROBE Oral Product SBDG · 1165931
  • ANTIROBE Pill SBDG · 1165932
  • Cleocin Oral Product SBDG · 1172331
  • Cleocin Pill SBDG · 1172332

📦 FDA Products & Package NDCs

15 products · 41 package NDCs
41 package NDCs map to RxCUI 309329 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0225-02 100 CAPSULE in 1 BOTTLE (0009-0225-02) Cleocin Hydrochloride Pharmacia & Upjohn Company LLC 1970-05-22
00009-0331-02 100 CAPSULE in 1 BOTTLE (0009-0331-02) Cleocin Hydrochloride Pharmacia & Upjohn Company LLC 1970-05-22
00009-0395-14 100 CAPSULE in 1 BOTTLE (0009-0395-14) Cleocin Hydrochloride Pharmacia & Upjohn Company LLC 1970-05-22
42571-0250-01 100 CAPSULE in 1 BOTTLE (42571-250-01) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0250-67 90 BLISTER PACK in 1 CARTON (42571-250-67) / 10 CAPSULE in... CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0251-01 100 CAPSULE in 1 BOTTLE (42571-251-01) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0251-05 500 CAPSULE in 1 BOTTLE (42571-251-05) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0251-10 1000 CAPSULE in 1 BOTTLE (42571-251-10) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0251-23 80 BLISTER PACK in 1 CARTON (42571-251-23) / 10 CAPSULE in... CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0252-01 100 CAPSULE in 1 BOTTLE (42571-252-01) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0252-05 500 CAPSULE in 1 BOTTLE (42571-252-05) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
42571-0252-10 1000 CAPSULE in 1 BOTTLE (42571-252-10) CLINDAMYCIN HYDROCHLORIDE Micro Labs Limited 2019-01-07
62135-0764-01 100 CAPSULE in 1 BOTTLE (62135-764-01) Clindamycin Hydrochloride Chartwell RX, LLC 2024-01-12
62135-0765-01 100 CAPSULE in 1 BOTTLE (62135-765-01) Clindamycin Hydrochloride Chartwell RX, LLC 2024-01-12
62135-0766-01 100 CAPSULE in 1 BOTTLE (62135-766-01) Clindamycin Hydrochloride Chartwell RX, LLC 2024-01-12
68462-0142-01 100 CAPSULE in 1 BOTTLE (68462-142-01) Clindamycin Hydrochloride GLENMARK PHARMACEUTICALS INC., USA 2023-03-10
68462-0143-01 100 CAPSULE in 1 BOTTLE (68462-143-01) Clindamycin Hydrochloride GLENMARK PHARMACEUTICALS INC., USA 2023-03-10
68462-0143-05 500 CAPSULE in 1 BOTTLE (68462-143-05) Clindamycin Hydrochloride GLENMARK PHARMACEUTICALS INC., USA 2023-03-10
68462-0144-01 100 CAPSULE in 1 BOTTLE (68462-144-01) Clindamycin Hydrochloride GLENMARK PHARMACEUTICALS INC., USA 2023-03-10
68462-0144-81 3 BLISTER PACK in 1 CARTON (68462-144-81) / 20 CAPSULE in 1... Clindamycin Hydrochloride GLENMARK PHARMACEUTICALS INC., USA 2023-03-10
76420-0614-01 100 CAPSULE in 1 BOTTLE (76420-614-01) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0614-12 12 CAPSULE in 1 BOTTLE (76420-614-12) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0614-20 20 CAPSULE in 1 BOTTLE (76420-614-20) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0614-21 21 CAPSULE in 1 BOTTLE (76420-614-21) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0614-30 30 CAPSULE in 1 BOTTLE (76420-614-30) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0614-60 60 CAPSULE in 1 BOTTLE (76420-614-60) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0614-90 90 CAPSULE in 1 BOTTLE (76420-614-90) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-01 100 CAPSULE in 1 BOTTLE (76420-615-01) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-12 12 CAPSULE in 1 BOTTLE (76420-615-12) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-20 20 CAPSULE in 1 BOTTLE (76420-615-20) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-21 21 CAPSULE in 1 BOTTLE (76420-615-21) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-30 30 CAPSULE in 1 BOTTLE (76420-615-30) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-60 60 CAPSULE in 1 BOTTLE (76420-615-60) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0615-90 90 CAPSULE in 1 BOTTLE (76420-615-90) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-01 100 CAPSULE in 1 BOTTLE (76420-616-01) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-12 12 CAPSULE in 1 BOTTLE (76420-616-12) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-20 20 CAPSULE in 1 BOTTLE (76420-616-20) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-21 21 CAPSULE in 1 BOTTLE (76420-616-21) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-30 30 CAPSULE in 1 BOTTLE (76420-616-30) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-60 60 CAPSULE in 1 BOTTLE (76420-616-60) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
76420-0616-90 90 CAPSULE in 1 BOTTLE (76420-616-90) CLINDAMYCIN HYDROCHLORIDE Asclemed USA, Inc. 2023-09-14
Observed labelers: Asclemed USA, Inc. (21) · Micro Labs Limited (9) · GLENMARK PHARMACEUTICALS INC., USA (5) · Chartwell RX, LLC (3) · Pharmacia & Upjohn Company LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.